Nordea Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $819K | Buy |
|
|||||
|
2025
Q1 | $1.05M | Buy |
|
|||||
|
2024
Q4 | $977K | Hold |
|
|||||
|
2024
Q3 | $1.04M | Sell |
|
|||||
|
2024
Q2 | $1.24M | Buy |
|
|||||
|
2024
Q1 | $1.21M | Buy |
|
|||||
|
2023
Q4 | $1.12M | Buy |
|
|||||
|
2023
Q3 | $983K | Sell |
|
|||||
|
2023
Q2 | $1.05M | Hold |
|
|||||
|
2023
Q1 | $1.12M | Hold |
|
|||||
|
2022
Q4 | $1.18M | Hold |
|
|||||
|
2022
Q3 | $996K | Buy |
|
|||||
|
2022
Q2 | $906K | Buy |
|
|||||
|
2022
Q1 | $668K | Hold |
|
|||||
|
2021
Q4 | $772K | Hold |
|
|||||
|
2021
Q3 | $666K | Hold |
|
|||||
|
2021
Q2 | $720K | Hold |
|
|||||
|
2021
Q1 | $656K | Hold |
|
|||||
|
2020
Q4 | $757K | Buy |
|
|||||
|
2020
Q3 | $590K | Sell |
|
|||||
|
2020
Q2 | $1.89M | Buy |
|
|||||
|
2020
Q1 | $634K | Buy |
|
|||||
|
2019
Q4 | $615K | Hold |
|
|||||
|
2019
Q3 | $497K | Buy |
|
|||||
|
2019
Q2 | $569K | Sell |
|
|||||
|
2019
Q1 | $637K | Sell |
|
|||||
|
2018
Q4 | $613K | Hold |
|
|||||
|
2018
Q3 | $699K | Buy |
|
|||||
|
2018
Q2 | $665K | Sell |
|
|||||
|
2018
Q1 | $5.21M | Sell |
|
|||||
|
2017
Q4 | $6.86M | Sell |
|
|||||
|
2017
Q3 | $9.12M | Sell |
|
|||||
|
2017
Q2 | $9.31M | Sell |
|
|||||
|
2017
Q1 | $9.76M | Buy |
|
|||||
|
2016
Q4 | $8.78M | Buy |
|
|||||
|
2016
Q3 | $9.02M | Sell |
|
|||||
|
2016
Q2 | $7.76M | Buy |
|
|||||
|
2016
Q1 | $6.11M | Buy |
|
|||||
|
2015
Q4 | $364K | Hold |
|
|||||
|
2015
Q3 | $366K | Buy |
|
|||||
|
2015
Q2 | $435K | Hold |
|
|||||
|
2015
Q1 | $396K | Hold |
|
|||||
|
2014
Q4 | $287K | Buy |
|
|||||
|
2014
Q3 | $118K | Sell |
|
|||||
|
2014
Q2 | $228K | Sell |
|
|||||
|
2014
Q1 | $1.61M | Sell |
|
|||||
|
2013
Q4 | $1.85M | Hold |
|
|||||
|
2013
Q3 | $1.9M | Sell |
|
|||||
|
2013
Q2 | $4.82M | Buy |
|